分析发现,自2019年以来实际工资下降了12%,US 的不平等现象加剧,超过了全球水平。根据来自 Oxfam 和全球最大的工会联合会 International Trade Union Confederation 的一项新分析,2025年全球 CEO 薪酬的增长速度比员工薪酬快20倍。经通胀调整后,2019年至2025年间全球员工薪酬下降了12%,相当于在此期间进行了108天的无偿工作。相比之下,CEO 薪酬在2019年至2025年间增长了54%。继续阅读...
Police say attack in Dunmurry in which no one was hurt shows ‘murderous intent still exists’ in paramilitaries“Murderous intent and capability” still exists within paramilitaries in Northern Ireland, officers have said after a car exploded outside a police station on the outskirts of Belfast.Detectives said they believed the New IRA was involved and are treating it as attempted murder. Continue reading...
Survey by global economic forum shows ‘tax wedge’ in Britain increased to 32.4% of income in 2025Business live – latest updatesTaxes on workers in Britain rose at the fastest rate among the world’s richest economies last year, according to the Organisation for Economic Cooperation and Development.With Labour under pressure on the economy amid the Iran war, the OECD said a key measure of the total tax paid by workers and their employers rose by the most in the 38-member club of rich nations in 2025. Continue reading...
• President Trump has moved to fast-track psychedelic research as part of his administration's policy agenda, marking a significant shift in federal drug policy priorities.
• Former Arizona Senator Kyrsten Sinema has publicly applauded the initiative as a "bold step forward" in medical research on Fox & Friends Weekend.
• The accelerated psychedelic research program represents an innovative approach to mental health treatment and scientific advancement under the Trump administration.
• The FDA announced the first ibogaine investigational new drug application as part of Trump's mental health executive order accelerating psychedelic drug approvals and research pathways.
• HHS will coordinate with the FDA and DEA to expedite research approval and clinical trial access for emerging mental health treatments under strict medical supervision and scientific oversight.
• The initiative specifically targets treatment-resistant conditions and addresses mental health needs among veterans and patients who have not responded to conventional therapies.